Clinical epidemiology of nonurothelial bladder cancer: analysis of the Netherlands Cancer Registry.

[1]  M. Oktay,et al.  Sex-specific hormone receptors in urothelial carcinomas of the human urinary bladder: a comparative analysis of clinicopathological features and survival outcomes according to receptor expression. , 2011, Urologic oncology.

[2]  J. Witjes,et al.  [Update of the Clinical Guidelines of the European Association of Urology on muscle-invasive and metastatic bladder carcinoma]. , 2010, Actas urologicas espanolas.

[3]  R. Shah,et al.  Multiple adverse histological features increase the odds of under staging T1 bladder cancer. , 2009, The Journal of urology.

[4]  N. Cook,et al.  Small cell carcinoma of the urinary bladder: a 15‐year retrospective review of treatment and survival in the Anglian Cancer Network , 2009, BJU international.

[5]  L. Kiemeney,et al.  The present and future burden of urinary bladder cancer in the world , 2009, World Journal of Urology.

[6]  C. Dinney,et al.  The impact of variant histology on the outcome of bladder cancer treated with curative intent. , 2009, Urologic oncology.

[7]  Arnulf Stenzl,et al.  Guidelines on Bladder Cancer Muscle-invasive and Metastatic , 2008 .

[8]  L. True,et al.  How wide is the spectrum of neuroendocrine carcinoma of the urinary bladder? , 2007, American journal of clinical pathology.

[9]  R. Montironi,et al.  Soft tissue tumors of the urinary bladder Part II: malignant neoplasms. , 2007, Human pathology.

[10]  E. Messing,et al.  Promotion of bladder cancer development and progression by androgen receptor signals. , 2007, Journal of the National Cancer Institute.

[11]  R. Dreicer,et al.  The atypical urothelial cancer patient: management of bladder cancers of non-transitional cell histology and cancers of the ureters and renal pelvis. , 2007, Seminars in oncology.

[12]  A. Carmack,et al.  Nonurothelial cancer of the bladder. , 2007, Urology.

[13]  S. Groshen,et al.  Radical cystectomy for primary neuroendocrine tumors of the bladder: the university of southern california experience. , 2005, The Journal of urology.

[14]  F. Guillé,et al.  Non‐transitional cell bladder carcinomas , 2005, BJU international.

[15]  M. Peyromaure,et al.  Surgical management of infiltrating bladder cancer in elderly patients. , 2004, European urology.

[16]  Paul W Dickman,et al.  Regression models for relative survival , 2004, Statistics in medicine.

[17]  A. Shokeir,et al.  Squamous cell carcinoma of the bladder: pathology, diagnosis and treatment , 2004, BJU international.

[18]  P. Dahm,et al.  Malignant non-urothelial neoplasms of the urinary bladder: a review. , 2003, European urology.

[19]  Gerhard Jakse,et al.  Guidelines on bladder cancer. , 2002, European urology.

[20]  Michael Cookson,et al.  Radical cystectomy is safe in elderly patients at high risk. , 2001, The Journal of urology.

[21]  M. Jewett,et al.  Primary low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type arising in the urinary bladder: report of 4 cases with molecular genetic analysis. , 2001, Archives of pathology & laboratory medicine.

[22]  L. Kiemeney,et al.  Gender differences in stage-adjusted bladder cancer survival. , 2000, Urology.

[23]  H. G. van der Poel,et al.  Gender differences in stage distribution of bladder cancer. , 2000, Urology.

[24]  V. Serretta,et al.  Pure Squamous Cell Carcinoma of the Bladder in Western Countries , 2000, European Urology.

[25]  S. Boyd,et al.  Radical cystectomy for elderly patients with bladder carcinoma , 1998, Cancer.

[26]  H. Akaza,et al.  Promoting effects and mechanisms of action of androgen in bladder carcinogenesis in male rats. , 1997, European urology.

[27]  S. Cohen,et al.  Epidemiology and etiology of bladder cancer. , 1992, The Urologic clinics of North America.

[28]  G. Zagars,et al.  Preoperative irradiation and radical cystectomy for stages T2 and T3 squamous cell carcinoma of the bladder. , 1990, The Journal of urology.